Search

A cesiated DC negative ion source has been developed for proton cyclotrons in medical applications. A continuous H− beam of 23 mA was stably extracted at an arc power of 3 kW. The beam current gradually decreases with a constant arc power and without additional Cs injection and the decay rate was about 0.03 mA (0.14%) per hour. A feed-back control system that automatically adjusts the arc power to stabilize the beam current is able to keep the beam current constant at ±0.04 mA (±0.2%).

A multi-cusp DC H− ion source has been developed for cyclotrons in medical use. Beam optics of the H− ion beam is studied using a 2D beam trajectory code. The simulation results are compared with the experimental results obtained in the Mark I source, which has produced up to 16 mA H− ion beams. The optimum extraction voltages show good agreement between the calculation and the experimental results. A new ion source, Mark II source, is designed to achieve the next goal of producing an H− beam of 20 mA. The magnetic field configurations and the plasma electrode design are optimized for Cs-seeded operation. Primary electron trajectory simulation shows that primary electrons are confined well and the magnetic filter prevents the primary electrons from entering into the extraction region.

Kyoto University Research Reactor Institute (KURRI) and Sumitomo Heavy Industries, Ltd. (SHI) have developed a cyclotron-based neutron source for Boron Neutron Capture Therapy (BNCT). It was installed at KURRI in Osaka prefecture. The neutron source consists of a proton cyclotron named HM-30, a beam transport system and an irradiation & treatment system. In the cyclotron, H- ions are accelerated and extracted as 30 MeV proton beams of 1 mA. The proton beams is transported to the neutron production target made by a beryllium plate. Emitted neutrons are moderated by lead, iron, aluminum and calcium fluoride. The aperture diameter of neutron collimator is in the range from 100 mm to 250 mm. The peak neutron flux in the water phantom is 1.8×109 neutrons/cm2/sec at 20 mm from the surface at 1 mA proton beam. The neutron source have been stably operated for 3 years with 30 kW proton beam. Various pre-clinical tests including animal tests have been done by using the cyclotron-based neutron source with 10B-p-Borono-phenylalanine. Clinical trials of malignant brain tumors will be started in this year.